Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001614107-17-000001
Filing Date
2017-02-21
Accepted
2017-02-21 15:47:28
Documents
1
Effectiveness Date
2017-02-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 10315
  Complete submission text file 0001614107-17-000001.txt   11391
Mailing Address 1616 EASTLAKE AVENUE E. SUITE 560 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVENUE E. SUITE 560 SEATTLE WA 98102 2064528700
Faraday Pharmaceuticals, Inc. (Filer) CIK: 0001614107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-221669 | Film No.: 17624955